These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8099457)
1. Evidence from molecular genetic and cytogenetic analyses that bone marrow histopathology is reliable in the diagnosis of chronic myeloproliferative disorders. Werner M; Kaloutsi V; Kausche F; Buhr T; Georgii A Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(4):199-204. PubMed ID: 8099457 [TBL] [Abstract][Full Text] [Related]
2. Karyotype findings and molecular analysis of the bcr gene rearrangement supplementing the histologic classification of chronic myeloproliferative disorders. Werner M; Nolte M; Kaloutsi V; Buhr T; Kausche F; Georgii A Lab Invest; 1995 Apr; 72(4):405-10. PubMed ID: 7723278 [TBL] [Abstract][Full Text] [Related]
3. [Morphometry of megakaryocytes for supporting the histologic diagnosis of chronic myeloproliferative diseases]. Nafe R; Holgado de Colombo S; Choritz H; Georgii A Pathologe; 1995 Jan; 16(1):34-40. PubMed ID: 7886012 [TBL] [Abstract][Full Text] [Related]
4. bcr gene rearrangement analysis in myeloproliferative disorders other than chronic myelogenous leukemia. Crisan D; Mattson JC; O'Malley BA; Schulz RW; Wilner F Cancer Detect Prev; 1996; 20(4):263-9. PubMed ID: 8818385 [TBL] [Abstract][Full Text] [Related]
5. [Cytogenetics and molecular studies confirm the histopathologic diagnosis of chronic myeloproliferative diseases]. Werner M; Nolte M; Ewing M; Kaloutsi V; Kausche F; Georgii A Pathologe; 1995 Jan; 16(1):41-5. PubMed ID: 7886013 [TBL] [Abstract][Full Text] [Related]
10. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias. Cox MC; Maffei L; Buffolino S; Del Poeta G; Venditti A; Cantonetti M; Aronica G; Aquilina P; Masi M; Amadori S Am J Clin Pathol; 1998 Jan; 109(1):24-31. PubMed ID: 9426514 [TBL] [Abstract][Full Text] [Related]
11. [Histopathology of Ph1-negative chronic myeloproliferative diseases]. Georgii A; Choritz H; Büsche G; Kreft A; Buhr T Pathologe; 1995 Jan; 16(1):62-9. PubMed ID: 7886016 [TBL] [Abstract][Full Text] [Related]
13. Megakaryocytes in chronic myeloproliferative disorders: numerical density correlated between different entities. Kaloutsi V; Fritsch RS; Buhr T; Restrepo-Specht I; Widjaja W; Georgii A Virchows Arch A Pathol Anat Histopathol; 1991; 418(6):493-7. PubMed ID: 2058083 [TBL] [Abstract][Full Text] [Related]
14. Chronic myeloproliferative diseases on a pathologist's desk--a dilemma of distinct entities versus a clinico-pathologic continuum. A descriptive study based on a material from the Polish population. Rudzki Z; Papla B; Stachura J Pol J Pathol; 2004; 55(1):13-23. PubMed ID: 15195702 [TBL] [Abstract][Full Text] [Related]
15. Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies. Nolte M; Werner M; Ewig M; von Wasielewski R; Link H; Diedrich H; Georgii A Virchows Arch; 1996 Mar; 427(6):561-5. PubMed ID: 8605566 [TBL] [Abstract][Full Text] [Related]
16. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes]. Bock O Verh Dtsch Ges Pathol; 2007; 91():140-53. PubMed ID: 18314608 [TBL] [Abstract][Full Text] [Related]
18. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders. Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609 [TBL] [Abstract][Full Text] [Related]
19. Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders. Nafe R; Georgii A; Kaloutsi V; Fritsch RS; Choritz H Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 61(2):111-6. PubMed ID: 1683718 [TBL] [Abstract][Full Text] [Related]
20. Detection of the activating JAK2 V617F mutation in paraffin-embedded trephine bone marrow biopsies of patients with chronic myeloproliferative diseases. Horn T; Kremer M; Dechow T; Pfeifer WM; Geist B; Perker M; Duyster J; Quintanilla-Martinez L; Fend F J Mol Diagn; 2006 Jul; 8(3):299-304. PubMed ID: 16825501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]